99 research outputs found

    On the zero of a radial minimizer of p-Ginzburg-Landau type

    Get PDF

    Interleukin-1Ī² inhibition for chronic kidney disease in obese mice with type 2 diabetes

    Get PDF
    An animal model with overt DKD is needed for preclinical study. Uninephrectomy is a common tool to accelerate kidney impairment but it has shortcomings such as lethality and kidney infection. Given that oxalate-rich diet is a convenient method to generate progressive nephrocalcinosis, tubular atrophy, and CKD in C56BL6 mice, we want to explore the possibility of using oxalate-rich diet as a substitutive and non-surgical approach to accelerate kidney impairment in db/db. We fed db/db mice of 14 weeks old with oxalate-rich diet or control diet for 30 days. We measured GFR every 10 days and analysed the crystal deposition in kidney after 30 days. We found that oxalate rich diet did not induce GFR loss and oxalate crystal deposition in kidney compared to mice with control diet. Inflammation is one of the center mechanisms leading to DKD. Infiltrated immune cells as well as renal resident cells release various cytokines which contribute to kidney function loss and structural alterations. Of the cytokines, IL-1Ī² is a key mediator in amplifying inflammation, such as upregulating chemokines and other cytokines. IL-1Ī² also contributes to kidney fibrosis. Thus IL-1Ī² serves as a potential target for DKD. Previous studies have shown that NLRP3-dependent IL-1Ī² from non-myeloid cell contribute to initiation and progression of DKD in diabetic mice, even though other studies suggested that non-myeloid cells may lack the ability to synthesis IL-1Ī². Our first aim was to investigate IL-1Ī² expression and possible cellular location in kidney. We observed IL-1Ī² expression was mildly increased in kidney biopsies from patients with diabetes at protein and mRNA level, as indicated by immunostaining and microarray, respectively. In a uninephrectomized db/db mice, IL-1Ī² gene expression level was also increased. Furthermore, human biopsy immunostainings demonstrated that IL-1Ī² was mainly located in infiltrated immune cells. Therefore, IL-1Ī² expression was induced in DKD and was mainly expressed by immune cells. Since we observed IL-1Ī² expression is increased in DKD, we hypothesized that targeting IL-1Ī² has a renal protective effect on DKD in animal model of DKD. To test this hypothesis, we treated 18-week-old db/db mice undergoing uninephrectomy at the age of 8 weeks with anti-IL-1Ī² IgG antibody or control IgG for 8 weeks. Mice treated with anti-IL-1Ī² IgG preserved higher glomerular filtration rate but comparable albuminuria level to those treated with control IgG. On glomerular structural changes, anti-IL-1Ī² antibody treatment did not affect glomerular tuft and Bowmanā€™s capsule size, nor collagen deposition in glomeruli. However, anti-IL-1Ī² showed higher podocyte account and higher expression levels of podocyte marker genes. IL-1Ī² blockade also reduced infiltrated macrophages in glomeruli. On fibrosis, IL-1Ī² blockade did not reduced alpha smooth muscle actin accumulation, but reduced fibrosis gene expression, such as Acta2 and Col4a3. In conclusion, (i) oxalate-rich diet did not induce massive oxalate crystal deposition in kidney nor GFR loss, thus is not a suitable method to generate overt DKD in db/db model. (ii) kidney IL-1Ī² expression mildly increased in human diabetes, and mainly originated from immune cells. Targeting IL-1Ī² by antibody generated a moderate effect on glomerular filtration rate decline, podocyte loss, and renal inflammation in type 2 diabetic mice with CKD. Whether these findings can translate into better outcomes also in human DKD remains to be determined

    Integrability and asymptotics of positive solutions of a Ī³-Laplace system

    Get PDF
    AbstractIn this paper, we use the potential analysis to study the properties of the positive solutions of a Ī³-Laplace system in Rnāˆ’div(|āˆ‡u|Ī³āˆ’2āˆ‡u)=upvq,āˆ’div(|āˆ‡v|Ī³āˆ’2āˆ‡v)=vpuq. Here 1<Ī³ā©½2, p,q>0 satisfy the critical condition p+q=Ī³āŽāˆ’1. First, the positive solutions u and v satisfy an integral system involving the Wolff potentials. We then use the method of regularity lifting to obtain an optimal integrability for this Wolff type integral system. Different from the case of Ī³=2, it is more difficult to handle the asymptotics since u and v have not radial structures. We overcome this difficulty by a new method and obtain the decay rates of u and v as |x|ā†’āˆž. We believe that this new method is appropriate to deal with the asymptotics of other decaying solutions without the radial structures
    • ā€¦
    corecore